Facebook
Twitter
Telegram
Report an ErrorADiTx Therapeutics Balance Sheet 2011-2024 | ADTX
Annual Balance Sheet ADiTx Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.94 M | 203 K | - | -8.66 M | 162 K | 47.9 K | -25 K | - | - | - | - | - | - |
Long Term Debt |
1.04 M | 1.89 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1 M | 1.09 M | - | 391 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 858 K | - | - | 25 K | - | - | - | - | - | - |
Total Current Liabilities |
25.9 M | 3.64 M | 3.61 M | 1.23 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
28.5 M | 5.53 M | 6.48 M | 2.09 M | 2.98 M | 1.65 M | 84.9 K | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-128 M | -95 M | -67.4 M | -20.9 M | -11.7 M | -5.9 M | -213 K | - | - | - | - | - | - |
Total Assets |
44.6 M | 10.7 M | 16.7 M | 13.1 M | 124 K | 116 K | 25 K | - | - | - | - | - | - |
Cash and Cash Equivalents |
97.1 K | 2.77 M | 7.87 M | 10.5 M | 4.09 K | - | - | - | - | - | - | - | - |
Book Value |
16 M | 5.21 M | 10.2 M | 11 M | -2.85 M | -1.54 M | -59.9 K | - | - | - | - | - | - |
Total Shareholders Equity |
16.1 M | 5.21 M | 10.2 M | 11 M | -2.85 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet ADiTx Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
892 K | 1.04 M | 1.2 M | 1.42 M | - | 1.89 M | - | - | - | 5 | 2.77 M | 2.96 M | 779 K | 858 K | 865 K | 858 K | 858 K | - | - | - | - | - | - | - | 35 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
18.2 M | 28.5 M | 12.4 M | 11.2 M | 7.57 M | 5.53 M | 6.49 M | 9.38 M | 7.07 M | 6.48 M | 6.61 M | 9.94 M | 6.65 M | 2.09 M | 2.09 M | 2.09 M | 2.09 M | 2.98 M | 2.98 M | 2.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-142 M | -128 M | -117 M | -107 M | -101 M | -95 M | -86.8 M | -79.3 M | -73.4 M | -67.4 M | -43.3 M | -33.4 M | -27.3 M | -20.9 M | -20.9 M | -20.9 M | -20.9 M | -11.7 M | -11.7 M | -11.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
28 M | 44.6 M | 8.23 M | 7.29 M | 7.63 M | 10.7 M | 19.2 M | 10.7 M | 11.8 M | 16.7 M | 19.6 M | 15.9 M | 18 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 124 K | 124 K | 124 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
88.7 K | 97.1 K | 1.65 M | 96 K | 303 K | 2.77 M | 9.24 M | 804 K | 2.12 M | 7.87 M | 5.47 M | 8.61 M | 14 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 4.09 K | 4.09 K | 4.09 K | - | 116 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
9.78 M | 16 M | -4.22 M | -3.87 M | 68.1 K | 5.21 M | 12.7 M | 1.36 M | 4.72 M | 10.2 M | 13 M | 5.96 M | 11.4 M | 11 M | 11 M | 11 M | 11 M | -2.85 M | -2.85 M | -2.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
9.93 M | 16.1 M | -4.22 M | -3.87 M | 68.1 K | 5.21 M | 12.7 M | 1.36 M | 4.72 M | 10.2 M | 13 M | 5.96 M | 11.4 M | 11 M | 11 M | 11 M | 11 M | -2.85 M | -2.85 M | -2.85 M | -1.81 M | -1.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency